Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EPS (Weighted Average and Diluted) (2021 - 2025)

Tenon Medical has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at -$0.22 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.22 for Q4 2025, down 103.0% from a year ago — trailing twelve months through Dec 2025 was -$1.99 (up 86.25% YoY), and the annual figure for FY2025 was -$1.7, up 84.9%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.22 at Tenon Medical, up from -$0.4 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for TNON hit a ceiling of $7.34 in Q4 2024 and a floor of -$3311.9 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$2.01 (2021), compared with a mean of -$176.71.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 509419.6% in 2023 and later soared 234.43% in 2024.
  • Tenon Medical's EPS (Weighted Average and Diluted) stood at -$2.96 in 2021, then skyrocketed by 73.99% to -$0.77 in 2022, then tumbled by 609.09% to -$5.46 in 2023, then skyrocketed by 234.43% to $7.34 in 2024, then tumbled by 103.0% to -$0.22 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.22 (Q4 2025), -$0.4 (Q3 2025), and -$0.36 (Q2 2025) per Business Quant data.